CDK9-IN-42
CDK9-IN-42 is a potent and selective CDK9 inhibitor with an IC50of 3.8 nM. CDK9-IN-42 can inhibit the growth of cancer cells and induce apoptosis by downregulating Myc-1 and c-Myc. CDK9-IN-42 can be used for the research of cancer, such as breast and lungcancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C22H19FN6O3S2
- Molecular Weight:498.55
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Caspase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
CDK9 3.8 nM (IC50) |
Caspase 3 |
In Vitro
CDK9-IN-42 (Compound L18) (72 h) inhibits proliferation of various hematological tumor cells, with IC50 values of 0.049 μM, 0.071 μM, 0.062 μM, 0.093 μM and 0.175 μM against MV4-11, MOLM-13, THP-1, KG-1, and HL-60 cells, respectively[1].
CDK9-IN-42 (72 h) inhibits proliferation of various solid tumor cells, with IC50 values of 0.045 μM, 0.166 μM, 0.247 μM and 0.225 μM against HepG2, MCF-7, 22RV1 and A549 cells, respectively[1].
CDK9-IN-42 (0.1-1 μM, 72 h) exhibits low cytotoxicity against normal human bronchial epithelial cells, with an IC50 of 0.402 μM against BEAS-2B cells[1].
CDK9-IN-42 shows excellent selectivity for CDK9 over other CDK family members, with IC50 >1 μM for CDK1, CDK4, CDK6, and CDK7[1].
CDK9-IN-42 (0.1-0.5 μM, 12 h) downregulates protein levels of p-RNAPII-ser2, Mcl-1, c-Myc, CDK9 and Cyclin T1 protein in MV4-11 cells[1].
CDK9-IN-42 (0.5-1 μM, 12 h) induces apoptosis in MV4-11 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MV4-11 cells
-
Concentration:0.1, 0.25, 0.5, 1 and 2 μM
-
Incubation Time:2, 4, 8, 12 and 24 h
-
Result:Decreased levels of p-RNAPII-ser2, Mcl-1, c-Myc, CDK9 and Cyclin T1 protein.
-
Cell Line:MV4-11 cells
-
Concentration:0.5 and 1 μM
-
Incubation Time:12 h
-
Result:Increased apoptosis rates.
Downregulated PARP and Caspase-3 proteins.
Upregulated Cleaved-PARP and Cleaved-Caspase-3.
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR mice[1]
-
Dosage:15, 30 and 50 mg/kg
-
Administration:Intravenously, Subcutaneous
-
Result:Showed no death or significant weight loss.
Chemical Information
-
Molecular Weight 498.55
-
Formel C22H19FN6O3S2
-
SMILES
FC1=CC(OC)=C(C2=NC=NC(NC3=CC(CS(C)(=NC(C4=CN=CS4)=O)=O)=CC=C3)=N2)C=C1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)